Modified power prior with multiple historical trials for binary endpoints.


Journal

Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016

Informations de publication

Date de publication:
30 03 2019
Historique:
received: 31 03 2018
revised: 08 09 2018
accepted: 04 10 2018
pubmed: 26 10 2018
medline: 29 7 2020
entrez: 26 10 2018
Statut: ppublish

Résumé

Including historical data may increase the power of the analysis of a current clinical trial and reduce the sample size of the study. Recently, several Bayesian methods for incorporating historical data have been proposed. One of the methods consists of specifying a so-called power prior whereby the historical likelihood is downweighted with a weight parameter. When the weight parameter is also estimated from the data, the modified power prior (MPP) is needed. This method has been used primarily when a single historical trial is available. We have adapted the MPP for incorporating multiple historical control arms into a current clinical trial, each with a separate weight parameter. Three priors for the weights are considered: (1) independent, (2) dependent, and (3) robustified dependent. The latter is developed to account for the possibility of a conflict between the historical data and the current data. We analyze two real-life data sets and perform simulation studies to compare the performance of competing Bayesian methods that allow to incorporate historical control patients in the analysis of a current trial. The dependent power prior borrows more information from comparable historical studies and thereby can improve the statistical power. Robustifying the dependent power prior seems to protect against prior-data conflict.

Identifiants

pubmed: 30360016
doi: 10.1002/sim.8019
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1147-1169

Informations de copyright

© 2018 John Wiley & Sons, Ltd.

Auteurs

Akalu Banbeta (A)

I-Biostat, UHasselt, Hasselt, Belgium.
Department of Statistics, Jimma University, Jimma, Ethiopia.

Joost van Rosmalen (J)

Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands.

David Dejardin (D)

F. Hoffmann-La Roche AG, Basel, Switzerland.

Emmanuel Lesaffre (E)

I-Biostat, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH